PenThymosin Alpha-1 10 mg
A thymic peptide studied for immune-modulation and host-defence research.
LL-37 PENImmune · Antimicrobial
A human cathelicidin-derived antimicrobial peptide studied for its broad antimicrobial activity, immune modulation and wound-research applications.
Available to verified researchers. Pricing and the batch Certificate of Analysis are shared on request.
LL-37 is the only human cathelicidin antimicrobial peptide, studied for direct antimicrobial action and a wide range of immunomodulatory effects in host-defence and wound research, here in a ready-to-use pen.
Features
LL-37 is supplied in the NADOVA LABS GoQuick pre-filled pen — a graduated, ready-to-use subcutaneous delivery format that removes reconstitution and simplifies repeat-dose study designs. Each pen is prepared from HPLC-verified material, dose-marked on the barrel, and shipped refrigerated with a Certificate of Analysis available per batch.
Handling & compliance
This pre-filled pen is intended strictly for in-vitro and laboratory research. It is not a drug, supplement, or medical device, and is not for human or veterinary use. Store refrigerated at 2–8 °C, protect from light, and follow accepted laboratory practice; exact specifications for your lot are listed on its Certificate of Analysis.
PenA thymic peptide studied for immune-modulation and host-defence research.
PenA thymic peptide complex studied for immune-regulation and ageing research.
Request a researcher account to view the Certificate of Analysis for this lot and place an order with the lab.